Recall in relation to valsartan cancer risk
There’s been a recall during the summer over valsartan cancer risks that have been identified. A recall has been triggered by regulators.
The Medicines and Healthcare products Regulatory Agency (MHRA) has been involved in the recall process. The recall has been triggered over impurities originating from the manufacturing process in China. The impurities are understood to be linked to cancer.
Patients using heart medications that contain valsartan are being asked to speak to their doctor or pharmacist ASAP.
Valsartan cancer risk links
The valsartan cancer risk links stem from reported impurities found in the manufacturing process in China. These impurities are said to potentially be cancer-causing.
The valsartan drugs are sold in the UK under the names of Diovan and Exforge. This medication is widely used for heart failure and high blood pressure, as well as for heart attack patients. It is the batches made by Dexcel Pharma Ltd and Accord Healthcare (previously Actavis Group) that reportedly are affected.
What you should do if you have valsartan cancer risk medication
If you have any of the valsartan cancer risk medication at the centre of the recall, the advice is to contact your doctor or pharmacist immediately. You should then be able to swap them for new batches that (we hope) are not affected by the issue.
This is a serious issue, and one that could, on the face of it, lead to a person falling victim to cancer. The issue with certain Chinese and Indian manufacturing plants has extended to other types of medications as well. In fact, there are already a number of legal actions being taken against pharmaceutical companies linked to a number of plants.
The valsartan cancer risk issue has arisen from impurities in the manufacturing process that should never have been allowed to happen. Pharmaceutical companies are responsible for the supply chain they choose to engage in. Legal action can be taken against suppliers for issues like the valsartan cancer risk scandal.
If you have been affected by this issue, please feel free to contact our legal team.
IMPORTANT: advice on this page is intended to be up-to-date for the 'first published date'.
Request a Callback from our team!
Fill out our quick call back form below and we’ll contact you when you’re ready to talk to us.
All fields marked * are required.
You have the right to object to the processing of your personal data.